These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 451183)

  • 1. Iosefamate meglumine: an iodinated contrast agent for hepatic computed tomography scanning.
    Koehler RE; Stanley RJ; Evens RG
    Radiology; 1979 Jul; 132(1):115-8. PubMed ID: 451183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental evaluation of iosefamate meglumine and its derivatives as hepatobiliary CT contrast agents.
    Seltzer SE; Hamilton C; VanDeripe D
    AJR Am J Roentgenol; 1985 Jul; 145(1):67-72. PubMed ID: 3873857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography of the liver in rhesus monkeys following losefamate meglumine administration.
    Moss AA; Brito AC
    Radiology; 1981 Oct; 141(1):123-7. PubMed ID: 7291516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of liposomes carrying losefamate for CT opacification of liver and spleen.
    Seltzer SE; Shulkin PM; Adams DF; Davis MA; Hoey GB; Hopkins RM; Bosworth ME
    AJR Am J Roentgenol; 1984 Sep; 143(3):575-9. PubMed ID: 6331738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast media for computer tomography of the liver.
    Wegener OH; Mützel W; Souchon R
    Acta Radiol Diagn (Stockh); 1980; 21(2A):239-47. PubMed ID: 7424559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomographic enhancement of liver and spleen in the dog with iodipamide ethyl ester particulate suspensions.
    Sands MS; Violante MR; Gadeholt G
    Invest Radiol; 1987 May; 22(5):408-16. PubMed ID: 3597009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of meglumine iotroxate in the detection of liver tumors by computed tomography.
    Hosoki T; Mori S
    Comput Radiol; 1985; 9(6):387-93. PubMed ID: 3004809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of meglumine iodipamide hepatotoxicity.
    Motoki T; Ikeuchi M; Hirano M; Yatsuji Y; Murao S
    Am J Gastroenterol; 1979 Jul; 72(1):71-4. PubMed ID: 463851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent.
    Marincek B; Young SW; Enzmann DR
    Invest Radiol; 1982; 17(1):90-4. PubMed ID: 7076441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High contrast enhancement of the liver in CT by repeated doses of contrast medium.
    Rossi P; Rovighi L; Tipaldi L; Bompiani C; Simonetti G
    Eur J Radiol; 1981 May; 1(2):126-31. PubMed ID: 7338235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iosulamide: a new intravenous cholangiocholecystographic medium.
    Rosenberg FJ; Ackerman JH; Nickel AR
    Invest Radiol; 1980; 15(6 Suppl):S142-7. PubMed ID: 6782035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of high contrast medium dose in brain CT.
    Raininko R; Majurin ML; Virtama P; Kangasniemi P
    J Comput Assist Tomogr; 1982 Feb; 6(1):54-7. PubMed ID: 7069012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of urographic and cholegraphic contrast enhanced CT liver scanning.
    Stephenson TF; Chang A; Pandya K; Ona F
    Comput Radiol; 1982; 6(5):257-62. PubMed ID: 7172643
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous cholangiography: experimental evaluation of the time-density-retention concept.
    Burgener FA
    AJR Am J Roentgenol; 1980 Apr; 134(4):665-7. PubMed ID: 6767349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AG 60.99: A promising contrast agent for computed tomography of the liver and spleen.
    Alfidi RJ; Laval-Jeantet M
    Radiology; 1976 Nov; 121(2):491. PubMed ID: 185647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Product selection criteria for intravascular ionic contrast media.
    Swanson DP; Dick TJ; Simms SM; Thrall JH
    Clin Pharm; 1985; 4(5):527-38. PubMed ID: 3902331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubular sludging of meglumine iodipamide (Biligrafin).
    Witcombe JB
    Br J Radiol; 1978 Aug; 51(608):579-83. PubMed ID: 678750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous cholangiography in normal and subsequently liver-damaged dogs.
    Burgener FA; Fischer HW
    Radiology; 1975 Mar; 114(3):519-24. PubMed ID: 1118550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of a particulate hepatolienographic CT contrast agent: a study of iodipamide ethyl ester in the rat.
    Violante MR; Måre K; Fischer HW
    Invest Radiol; 1981; 16(1):40-5. PubMed ID: 7216695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. II: The renal medulla.
    Brennan RE; Curtis JA; Pollack HM; Weinberg I
    Invest Radiol; 1979; 14(3):239-45. PubMed ID: 468497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.